Stock screener

BEAM

Conviction 27HealthcareScan · Mon, Aug 10, 2026
BEAM$27.25-0.84%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.68M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Beam Therapeutics Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.beamtx.com ↗
Price27.25
Change-0.84%
Gap+0.07%
Rel volume0.53×
Avg volume1.89M
Avg $ vol51.17M
SMA 2027.08
SMA 5030.44
SMA 20028.09
Price vs 50-10.47%
Price vs 200-3.00%
MA stackmixed
50/200 cross—
Supertrenddown · 30.63
RSI (14)45
MACD hist0.27
MACD crossbull · 4d
Stoch %K / %D68 / 70
ADX (14)23
+DI / −DI17 / 20
RSI divergence—
MACD divergence—
ATR %+6.37%
ADR %5.34%
52w high37.92
52w low16.01
From 52w high-28.14%
Above 52w low+70.21%
New 52w highNo
SqueezeOff
Bollinger width22.98%
%B0.53
Donchian pos37.50%
Donchian high31.55
Donchian low24.67
AVWAP (52w high)29.56
vs AVWAP high-7.83%
AVWAP (52w low)27.21
vs AVWAP low+0.16%
OBV trendDown
Chaikin MF (20)-0.18
Today vs 20d0.53×
Avg vol (14d)1.68M
Avg vol (20d)1.89M
Avg $ vol (20d)51.17M
Market cap2.81B
RS 3m (vs SPY)-18.38%
RS 6m (vs SPY)-2.99%
RS line new highNo
Trend template4/8
Technical rank29.1
1 week+5.17%
1 month-16.62%
3 months-15.69%
6 months+2.75%
1 year+52.58%
YTD+0.41%
P/E-35.19
P/B2.64
P/S20.14
P/FCF-7.82
EPS-0.8100
Div yield—
ROE-7.49%
ROA-5.77%
Debt/Eq0.09
Current14.57
EV/EBITDA-7.46
Gross margin—
Net margin-57.24%
Rev growth120.01%
EPS growth78.77%
Price target52.50
Target upside92.66%
Analyst ratingBuy
Institutional117.82%
Ent. value2.7B
Revenue490K
Net income-122.68M
Gross profit—
Free cash flow-360.05M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out102.88M
Employees522
ListedThu, Feb 6, 2020
Free float79.74M
Float %78.3%
Short interest23.22M
Days to cover8.9d
Short volume81.3%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.18 vs −$1.00
Last surprise-18.0% miss
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank29.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance37.57
Support24.67
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jun 18 – Jun 24
    2 scans
  2. Breaking out now
    Jun 26
    1 scan
  3. Broke out
    Jun 29
    1 scan

Congress activity

Disclosed STOCK Act trades in BEAM

All disclosures →
No recent disclosed trades by Congress in BEAM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BEAM · 6 buys · 4 sells

InsiderSideShares
FMR LLC
10% owner · Common Stock · 2026-06-26
Sell251.49K
FMR LLC
10% owner · Common Stock · 2026-06-25
Sell33.37K
Ciaramella Giuseppe
President · Common Stock · 2026-06-17
Exercise6.5K
Ciaramella Giuseppe
President · Common Stock · 2026-06-17
Exercise29K
Ciaramella Giuseppe
President · Stock Option (Right to Buy) · 2026-06-17
Exercise6.5K
Ciaramella Giuseppe
President · Stock Option (Right to Buy) · 2026-06-17
Exercise29K
Shaw Christi
Director · Stock Option (Right to Buy) · 2026-06-03
Grant19.68K
Fishman Mark
Director · Stock Option (Right to Buy) · 2026-06-03
Grant19.68K
MARAGANORE JOHN
Director · Stock Option (Right to Buy) · 2026-06-03
Grant19.68K
COOPER GRAHAM K
Director · Stock Option (Right to Buy) · 2026-06-03
Grant19.68K

SEC filings

EDGAR filings in BEAM · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.